Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting

Integer (NYSE: ITGR) will exhibit at the North American Neuromodulation Society Annual Meeting in Las Vegas from Jan. 22–25, 2026.

Rhea-AI Summary

Integer (NYSE: ITGR) will exhibit at the North American Neuromodulation Society Annual Meeting in Las Vegas from Jan. 22–25, 2026. Visit booth #115 to see Integer’s work on neuromodulation and miniaturized active implantable medical devices (AIMDs) aimed at accelerating development timelines and reducing risk for device makers.

Integer will highlight full-system capabilities—from high-performance batteries to integrated implantable pulse generators and lead systems—and showcase the Xcellion® Gen 3 Fast Charge Lithium Ion battery, which offers best-in-class runtime and recharges in as little as 30 minutes.

Argus Jan 14 session

+2.37% close to close Open Argus

Details

News Market Reaction – ITGR

In the Jan 14 session, ITGR gained 2.37%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Integer’s neuromodulation and miniaturized implantable device capabilit...

Analysis

This announcement highlights Integer’s neuromodulation and miniaturized implantable device capabilities ahead of the NANS 2026 meeting, including its Xcellion Gen 3 fast-charge battery that recharges in as little as 30 minutes. In the past six months, more material drivers included Q3 2025 results with $467.7M in sales and a $200M share repurchase authorization. Investors may watch how conference visibility translates into new development programs, as well as future earnings and leverage trends.

Key Figures

Conference dates: Jan. 22–25, 2026 Booth number: #115 Recharge time: 30 minutes

Conference dates

Jan. 22–25, 2026

NANS Annual Meeting schedule

Booth number

#115

Integer exhibit location at NANS 2026

Recharge time

30 minutes

Xcellion Gen 3 battery fast-charge capability

Historical Context

5 past events · Latest: Nov 18

5 events

1. Nov 18

   Investor conferences

   24h Move

   +1.0%

   Management highlighted upcoming participation in two healthcare investor conferences.

2. Nov 04

   Share repurchase

   24h Move

   +2.5%

   Board authorized a $200M share repurchase program funded by cash and free cash flow.

3. Oct 24

   CEO transition

   24h Move

   -1.3%

   Planned transition as Payman Khales assumed President and CEO role from retiring CEO.

4. Oct 23

   Q3 2025 earnings

   24h Move

   -32.3%

   Reported Q3 sales $467.7M, EPS $1.79, higher leverage at $1.194B debt and 3.0x ratio.

5. Sep 25

   Earnings call setup

   24h Move

   -1.2%

   Scheduled Q3 2025 earnings call with webcast and replay details for investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

neuromodulation, active implantable medical devices, implantable pulse generator, lithium ion battery

4 terms

neuromodulation medical

"Integer will spotlight its latest advancements in neuromodulation and next-generation"

Neuromodulation is the use of devices or targeted treatments to change how nerves or brain circuits send signals, much like adjusting the volume or tuning on an audio system to alter what you hear. For investors, it matters because these therapies can treat chronic conditions (pain, movement disorders, depression) where existing medicines fall short, creating potential markets, regulatory milestones, and durable revenue streams if technologies prove safe and effective.

active implantable medical devices medical

"next-generation miniaturized active implantable medical devices (AIMDs)."

Active implantable medical devices are electronic devices placed inside the body that use power (like a battery or external source) to monitor, support, or change biological functions — for example pacemakers, cochlear implants, and neurostimulators. Investors care because these devices involve long development cycles, strict safety and regulatory oversight, and recurring revenue from replacements, follow-up care, and software updates, much like buying a durable product that also requires ongoing service.

implantable pulse generator medical

"from high-performance batteries to fully integrated implantable pulse generator and lead systems"

An implantable pulse generator is a small, battery-powered medical device placed under the skin that sends controlled electrical pulses to nerves or tissues to treat chronic pain, movement disorders, or other conditions. Investors watch these devices because approvals, device longevity, battery or recharge technology, and surgical and replacement demand drive sales, recurring revenue, and clinical adoption — similar to how a reliable power source affects the usefulness of any electronic tool.

lithium ion battery technical

"Xcellion® Gen 3 Fast Charge Lithium Ion battery technology, which offers best-in-class"

A lithium ion battery is a common rechargeable energy pack that stores and releases electricity by moving charged lithium particles between internal parts, powering devices from phones to electric cars. Investors care because battery size, cost, lifespan and raw material needs (like lithium and other metals) directly affect product prices, company margins and supply chains; improvements or shortages can change demand, profits and valuations across tech and automotive sectors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

~ Attendees Invited to Visit Integer at Booth #115 ~

PLANO, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) --  Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas from Jan. 22 – 25, 2026.

At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices (AIMDs). These innovations are designed to accelerate development timelines and reduce risk for medical device companies bringing novel therapies to market.

“Miniaturization is transforming the future of implantable technologies, and we’re proud to partner with customers to make that future a reality,” said Jim Stephens, President, Cardiac Rhythm Management & Neuromodulation. “We invite attendees to visit booth #115 to see how Integer’s expertise – spanning every critical component from high-performance batteries to fully integrated implantable pulse generator and lead systems – can help enable our customers’ innovations.”

Attendees can also explore Integer’s Xcellion^® Gen 3 Fast Charge Lithium Ion battery technology, which offers best-in-class runtime and recharges in as little as 30 minutes.

Learn more about Integer at www.integer.net.

About Integer^®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, Integer is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company’s brands include Greatbatch Medical^® and Lake Region Medical^®. Additional information is available at www.integer.net.

Investor Relations:			Media Relations:
Kristen Stewart			Misty Tippen
kristen.stewart@integer.net			misty.tippen@integer.net
551.337.3973			469.536.6702

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When and where will Integer (ITGR) exhibit at NANS 2026?

Integer will exhibit in Las Vegas from Jan. 22–25, 2026 at booth #115.

What technologies will Integer (ITGR) showcase at NANS 2026?

Integer will spotlight neuromodulation, miniaturized AIMDs, integrated pulse generator and lead systems, and the Xcellion Gen 3 Fast Charge battery.

What is notable about Integer’s Xcellion Gen 3 battery featured by ITGR?

The Xcellion Gen 3 Fast Charge Lithium Ion battery claims best-in-class runtime and can recharge in as little as 30 minutes.

How can medical device companies engage with Integer (ITGR) at the show?

Attendees can visit booth #115 to discuss Integer’s end-to-end CDMO capabilities and miniaturization expertise.

Will Integer (ITGR) demonstrate full implantable systems at NANS 2026?

Yes; Integer will present capabilities spanning batteries to fully integrated implantable pulse generator and lead systems.

Where can investors find more information about Integer (ITGR) after NANS 2026?

More information is available on Integer’s website; attendees can also follow post-event updates and product details online.